Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors
Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors
Abstract Recently proposed tumor fitness measures, based on profiling neoepitopes for reactive viral epitope similarity, have been proposed to predict response to immune checkpoint inhibitors in melanoma and small-cell lung cancer. Here we apply these checkpoint based fitness measures measures to the matched checkpoint treatment naive TCGA samples where cytolytic activity imparts a known survival benefit. We observed no significant survival predictive power beyond that of overall patient tumor mutation burden, and furthermore, found no association between checkpoint based fitness and tumor T-cell infiltration, cytolytic activity (CYT), and abundance (TIL burden). In addition, we investigated the key assumption of viral epitope similarity driving immune response in the hepatitis B virally infected liver cancer TCGA cohort, and uncover suggestive evidence that tumor neoepitopes actually dominate viral epitopes in putative immunogenicity and plausibly drive immune response and recruitment.
Villanueva Augusto、Akers Nicholas、Gonzalez-Kozlova Edgar、Losic Bojan、Bubie Adrian
Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount SinaiAdaptive biotechnologiesDepartment of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount SinaiDepartment of Genetics and Genomic Sciences, Tisch Cancer Institute, Cancer Immunology, Diabetes, Obesity and Metabolism Institute, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount SinaiDepartment of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
肿瘤学医学研究方法基础医学
Villanueva Augusto,Akers Nicholas,Gonzalez-Kozlova Edgar,Losic Bojan,Bubie Adrian.Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors[EB/OL].(2025-03-28)[2025-08-02].https://www.biorxiv.org/content/10.1101/679886.点此复制
评论